NASDAQ:ARCC - Ares Capital Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $16.75
  • Forecasted Upside: -9.56 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$18.52
▼ -0.24 (-1.28%)
1 month | 3 months | 12 months
Get New Ares Capital Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARCC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARCC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$16.75
▼ -9.56% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for Ares Capital in the last 3 months. The average price target is $16.75, with a high forecast of $20.00 and a low forecast of $15.00. The average price target represents a -9.56% upside from the last price of $18.52.
Buy
The current consensus among 10 polled investment analysts is to buy stock in Ares Capital. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/10/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/7/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/5/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/4/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/2/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2021CitigroupBoost Price Target$17.00 ➝ $20.00Low
i
2/11/2021Raymond JamesBoost Price TargetOutperform$17.50 ➝ $19.00Low
i
1/8/2021Raymond JamesBoost Price TargetOutperform$16.00 ➝ $17.50Low
i
12/10/2020JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
i
12/10/2020BarclaysDowngradeOverweight ➝ Equal Weight$16.00 ➝ $17.00Medium
i
10/27/2020Janney Montgomery ScottUpgradeNeutral ➝ BuyMedium
i
8/5/2020Raymond JamesBoost Price TargetOutperform$15.50 ➝ $16.00Low
i
8/5/2020CitigroupBoost Price TargetBuy$15.00 ➝ $17.00Medium
i
8/4/2020OppenheimerInitiated CoverageBuy$16.00Medium
i
Rating by Chris Kotowski at Oppenheimer Holdings Inc.
6/24/2020Raymond JamesBoost Price TargetOutperform$14.00 ➝ $15.50Medium
i
6/17/2020JMP SecuritiesBoost Price TargetMarket Outperform$15.00 ➝ $15.50Low
i
5/7/2020CitigroupBoost Price TargetBuy$13.00 ➝ $15.00Low
i
5/4/2020JPMorgan Chase & Co.Lower Price TargetOverweight$19.50 ➝ $15.50Low
i
4/16/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$14.00Medium
i
4/13/2020OppenheimerLower Price TargetOutperform$19.00 ➝ $16.00High
i
4/13/2020Bank of AmericaUpgradeNeutral ➝ Buy$16.00Low
i
4/7/2020CitigroupLower Price TargetBuy$20.00 ➝ $13.00High
i
4/2/2020Compass PointUpgradeNeutral ➝ BuyHigh
i
3/25/2020Wells Fargo & CompanyLower Price TargetOverweight$20.50 ➝ $15.00Low
i
11/12/2019Royal Bank of CanadaInitiated CoverageOutperform$20.00Low
i
10/22/2019Raymond JamesDowngradeOutperform ➝ Market PerformLow
i
Rating by Robert Dodd at Raymond James
8/23/2019Compass PointDowngradeBuy ➝ NeutralMedium
i
8/19/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$19.00 ➝ $20.00Low
i
Rating by Lana Chan at BMO Capital Markets
7/31/2019BMO Capital MarketsSet Price TargetHold$19.00N/A
i
Rating by Lana Chan at BMO Capital Markets
7/31/2019Raymond JamesBoost Price TargetOutperform$19.00 ➝ $19.50Low
i
5/14/2019WedbushSet Price TargetBuy$20.00Low
i
Rating by Henry Coffey at Wedbush
5/1/2019National SecuritiesReiterated RatingBuy$20.00Medium
i
2/13/2019JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$19.00 ➝ $19.50Low
i
2/13/2019National SecuritiesBoost Price TargetBuy$19.00 ➝ $20.00Low
i
11/1/2018OppenheimerSet Price TargetBuy$18.00Low
i
Rating by Allison M. Taylor at Oppenheimer Holdings Inc.
11/1/2018National SecuritiesReiterated RatingBuy$19.00Low
i
8/23/2018CitigroupInitiated CoverageBuy ➝ Buy$19.00Low
i
8/6/2018National SecuritiesReiterated RatingBuy$19.00Low
i
6/4/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$18.00 ➝ $18.50Low
i
5/15/2018National SecuritiesReiterated RatingBuy$19.00Low
i
5/3/2018OppenheimerSet Price TargetBuy$18.00Low
i
Rating by Allison M. Taylor at Oppenheimer Holdings Inc.
5/3/2018National SecuritiesReiterated RatingBuy$19.00Low
i
4/11/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$16.50 ➝ $17.00Low
i
3/26/2018National SecuritiesReiterated RatingBuy$19.00Low
i
2/15/2018National SecuritiesReiterated RatingBuy$19.00Low
i
2/13/2018OppenheimerSet Price TargetBuy$18.00Low
i
Rating by Allison M. Taylor at Oppenheimer Holdings Inc.
12/6/2017Compass PointInitiated CoverageBuy ➝ Buy$17.50Low
i
11/27/2017WedbushInitiated CoverageOutperform$18.00Low
i
Rating by H. Coffey at Wedbush
11/3/2017National SecuritiesReiterated RatingBuy$19.00N/A
i
11/3/2017Jefferies Financial GroupReiterated RatingBuy$19.50N/A
i
10/6/2017Keefe, Bruyette & WoodsSet Price TargetBuy$19.00N/A
i
9/21/2017CIBCInitiated CoverageOutperform ➝ Outperform$18.00Low
i
9/21/2017OppenheimerInitiated CoverageOutperform$18.00Low
i
9/20/2017CitigroupInitiated CoverageOutperform$18.00Low
i
8/25/2017BMO Capital MarketsReiterated RatingHold$15.00Low
i
8/7/2017National SecuritiesReiterated RatingBuy$19.00Low
i
7/14/2017Jefferies Financial GroupReiterated RatingBuy$19.50Low
i
6/16/2017Keefe, Bruyette & WoodsReiterated RatingBuy$18.50Low
i
6/1/2017BMO Capital MarketsReiterated RatingHold$15.00Low
i
5/15/2017Janney Montgomery ScottReiterated RatingNeutralN/A
i
5/8/2017National SecuritiesUpgradeNeutral ➝ Buy$18.00 ➝ $19.00Low
i
5/5/2017Janney Montgomery ScottReiterated RatingNeutralLow
i
4/11/2017BMO Capital MarketsReiterated RatingHold$15.00Low
i
4/7/2017Jefferies Financial GroupReiterated RatingBuy$19.50Low
i
3/6/2017CitigroupBoost Price TargetBuy$16.00 ➝ $19.00N/A
i
2/24/2017National SecuritiesBoost Price TargetNeutral$16.00 ➝ $18.00N/A
i
2/23/2017Jefferies Financial GroupReiterated RatingBuy$17.50 ➝ $19.50N/A
i
1/9/2017National SecuritiesReiterated RatingNeutral$16.00N/A
i
1/8/2017BarclaysSet Price TargetBuy$18.00N/A
i
Rating by Mark Devries at Barclays PLC
1/4/2017Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Jonathan Bock at Wells Fargo & Company
11/4/2016National SecuritiesReiterated RatingNeutral$16.00N/A
i
11/3/2016JMP SecuritiesReiterated RatingBuyN/A
i
11/3/2016BarclaysReiterated RatingBuyN/A
i
10/31/2016Janney Montgomery ScottInitiated CoverageNeutral$16.50N/A
i
10/25/2016Jefferies Financial GroupReiterated RatingBuy$17.50N/A
i
Rating by John Hecht at Jefferies Financial Group Inc.
8/18/2016UBS GroupLower Price TargetBuy$19.00 ➝ $17.50N/A
i
8/9/2016JMP SecuritiesBoost Price TargetMarket Outperform$16.00 ➝ $17.00N/A
i
8/4/2016Keefe, Bruyette & WoodsBoost Price TargetOutperform$17.00 ➝ $17.50N/A
i
8/4/2016Jefferies Financial GroupReiterated RatingBuy$17.50N/A
i
Rating by John Hecht at Jefferies Financial Group Inc.
8/4/2016National SecuritiesReiterated RatingNeutral$16.00N/A
i
6/28/2016National SecuritiesInitiated CoverageNeutral$16.00N/A
i
5/24/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by John Hecht at Jefferies Financial Group Inc.
5/5/2016Jefferies Financial GroupReiterated RatingBuy$17.50N/A
i
(Data available from 3/4/2016 forward)
Ares Capital logo
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
Read More

Today's Range

Now: $18.52
$18.27
$18.92

50 Day Range

MA: $17.76
$16.93
$18.70

52 Week Range

Now: $18.52
$7.90
$18.92

Volume

2,799,262 shs

Average Volume

2,275,244 shs

Market Capitalization

$7.83 billion

P/E Ratio

24.69

Dividend Yield

8.53%

Beta

1.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Ares Capital?

The following Wall Street analysts have issued research reports on Ares Capital in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Compass Point, Janney Montgomery Scott, JMP Securities, JPMorgan Chase & Co., Oppenheimer Holdings Inc., Raymond James, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for ARCC.

What is the current price target for Ares Capital?

8 Wall Street analysts have set twelve-month price targets for Ares Capital in the last year. Their average twelve-month price target is $16.75, suggesting a possible downside of 9.6%. Citigroup Inc. has the highest price target set, predicting ARCC will reach $20.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $15.00 for Ares Capital in the next year.
View the latest price targets for ARCC.

What is the current consensus analyst rating for Ares Capital?

Ares Capital currently has 2 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ARCC will outperform the market and that investors should add to their positions of Ares Capital.
View the latest ratings for ARCC.

What other companies compete with Ares Capital?

How do I contact Ares Capital's investor relations team?

Ares Capital's physical mailing address is 245 PARK AVENUE 44TH FLOOR, NEW YORK NY, 10167. The investment management company's listed phone number is 212-750-7300 and its investor relations email address is [email protected] The official website for Ares Capital is www.arescapitalcorp.com.